SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+18%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$271M
AUM Growth
+$271M
(+46%)
Cap. Flow
+$68.2M
Cap. Flow
% of AUM
25.15%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
68
New
19
Increased
25
Reduced
11
Closed
9
Top Buys
| 1 |
Novo Nordisk
NVO
|
$7.06M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.08M |
| 3 |
Sanofi
SNY
|
$5.76M |
| 4 |
CELG
Celgene Corp
CELG
|
$5.66M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.21M |
Top Sells
| 1 |
Cigna
CI
|
$7.6M |
| 2 |
UnitedHealth
UNH
|
$6.98M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$5.38M |
| 4 |
Zimmer Biomet
ZBH
|
$2.07M |
| 5 |
Intuitive Surgical
ISRG
|
$2M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Energy | 1.43% |
| 3 | Utilities | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
| $9.44M | 3.48% |
35,000
+2,500
| +8% | +$674K |
|
2
Eli Lilly
LLY
$657B
| $9.08M | 3.35% |
70,000
+15,000
| +27% | +$1.95M |
|
3
Boston Scientific
BSX
$156B
| $8.64M | 3.18% |
225,000
+5,000
| +2% | +$192K |
|
4
Baxter International
BAX
$12.7B
| $8.54M | 3.15% |
105,000
+45,000
| +75% | +$3.66M |
|
5
Abbott
ABT
$231B
| $7.99M | 2.95% |
100,000
-15,000
| -13% | -$1.2M |
|
6
Humana
HUM
$36.5B
| $7.98M | 2.94% |
30,000
+10,000
| +50% | +$2.66M |
|
7
Danaher
DHR
$147B
| $7.92M | 2.92% |
60,000
+15,000
| +33% | +$1.98M |
|
8
Merck
MRK
$210B
| $7.9M | 2.91% |
95,000
| – | – |
|
9
Elevance Health
ELV
$71.8B
| $7.89M | 2.91% |
27,500
+5,000
| +22% | +$1.43M |
|
10
HCA Healthcare
HCA
$94.5B
| $7.82M | 2.88% |
60,000
+25,000
| +71% | +$3.26M |
|
11
Molina Healthcare
MOH
$9.8B
| $7.81M | 2.88% |
55,000
+25,000
| +83% | +$3.55M |
|
|
12
Novo Nordisk
NVO
$251B
| $7.06M | 2.6% |
+135,000
| New | +$7.06M |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $6.11M | 2.25% |
20,000
+7,500
| +60% | +$2.29M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.08M | 2.24% |
+45,000
| New | +$6.08M |
|
15
AstraZeneca
AZN
$248B
| $6.07M | 2.23% |
150,000
+14,600
| +11% | +$590K |
|
16
Universal Health Services
UHS
$11.6B
| $6.02M | 2.22% |
45,000
+5,000
| +13% | +$669K |
|
17
Stryker
SYK
$150B
| $5.93M | 2.18% |
30,000
-5,000
| -14% | -$988K |
|
|
18
Sanofi
SNY
$121B
| $5.76M | 2.12% |
+130,000
| New | +$5.76M |
|
|
19
Intuitive Surgical
ISRG
$170B
| $5.71M | 2.1% |
10,000
-3,500
| -26% | -$2M |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $5.66M | 2.09% |
+60,000
| New | +$5.66M |
|
21
Elanco Animal Health
ELAN
$9.12B
| $5.61M | 2.07% |
175,000
+91,363
| +109% | +$2.93M |
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $5.52M | 2.03% |
30,000
-5,000
| -14% | -$920K |
|
23
Thermo Fisher Scientific
TMO
$186B
| $5.47M | 2.02% |
20,000
+5,000
| +33% | +$1.37M |
|
24
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.34M | 1.97% |
13,000
+3,000
| +30% | +$1.23M |
|
25
Incyte
INCY
$16.5B
| $5.16M | 1.9% |
60,000
+25,000
| +71% | +$2.15M |
|